 Methyl prednisolone double-lumen gel-saline submuscular mammary prostheses double-blind prospective clinical trial time immediate breast reconstruction submuscular implants consecutive patients breasts groups gel-saline double-lumen implant cc saline outer lumen implant cc saline mg methyl prednisolone Patients minimum years groups patient age implant size months capsular contracture steroid atrophy complications completion double-blind study patients submuscular gel-saline implants saline overall capsular contracture rate percent months percent months percent months methyl prednisolone overall capsular contracture rate percent months unchanged end study rates complications comparable Methyl prednisolone dose mg cc saline concentration mg outer lumen double-lumen gel-saline implant submuscular pocket safe efficacious risk capsular contracture minimum years patients immediate breast reconstruction submuscular mammary implants